Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

Share Price is delayed by 15 minutes
Get Live Data
38.75    -2.05 (-5.02%)
Bid:
39.00
Ask:
39.40
Spread: 0.40 (1.026%)
Market Cap: £515.78m
IQE Live PriceLast checked at - London Stock Exchange

Intraday IQE Share Chart

Completion of Placing

8 Feb 2012 16:10

RNS Number : 0704X
IQE PLC
08 February 2012
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, JAPAN, THE REPUBLIC OF IRELAND OR SOUTH AFRICA, OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

 

 

IQE plc

 

Completion of Placing to raise £10.5 million

 

Cardiff, UK, 8 February 2012: IQE plc (AIM:IQE, "IQE" or the "Group"), a leading global supplier of advanced semiconductor wafer products and services to the semiconductor industry, has successfully placed 43,750,000 new ordinary shares of 1 pence each ("Placing Shares") at a price of 24 pence per Placing Share (the "Placing Price") raising gross proceeds of £10.5 million.

 

Further details of the Placing and the Group's strategic investment in Solar Junction Corporation are set out in the announcement released earlier today.

 

Application has been made for the Placing Shares to be admitted to trading on AIM and it is expected that admission will take place at 8.00 a.m. on 13 February 2012. 

 

Drew Nelson, Chief Executive of IQE commented:

 

"We are delighted that both existing and new institutional shareholders have supported the fund raising which will allow us to significantly accelerate our well established CPV strategy.

 

"Our investment in Solar Junction, with its world beating CPV cell technology, is an outstanding opportunity for us to become a key supplier of epi wafer and materials to the CPV market. The investment also brings us access to Solar Junction's well-funded R&D."

 

Enquiries:

 

IQE plc

+44 (0) 29 2083 9400

Drew Nelson

Phil Rasmussen

Chris Meadows

Espirito Santo Investment Bank

+ 44 (0) 20 7456 9191

Richard Crawley/James Bromhead/Alastair Maclachlan

Canaccord Genuity

+ 44 (0) 20 7050 6500

Simon Bridges/Cameron Duncan

College Hill

+44 (0) 20 7457 2020

Adrian Duffield/ Kay Larsen

 

 

This Announcement has been issued by, and is the sole responsibility of, the Company.

 

Execution Noble & Company Limited which is authorised and regulated in the United Kingdom by the Financial Services Authority (the "FSA"), is acting as Nominated Adviser and broker to the Company for the purposes of the AIM Rules for Companies and the AIM Rules for Nominated Advisers in connection with the Placing and Admission and is not acting for, and will not be responsible to, any person other than the Company for providing the protections afforded to customers of Execution Noble & Company Limited or for advising any other person on any transaction or arrangement referred to in this announcement. Execution Noble Limited, which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively as financial adviser to and broker to IQE plc and for no one else in connection with the Placing and is not advising any other person or treating any other person as its customer in relation to or in connection with the Placing and is not advising any other person or treating any other person as its customer in relation to the matters referred to in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Execution Noble Limited or for providing advice in relation to the Placing or any matter referred to in this announcement. Together Execution Noble & Company Limited and Execution Noble Limited carry out their UK investment banking business as Espirito Santo Investment Bank ("BESI").

 

Canaccord Genuity Limited ("Canaccord"), which is authorised and regulated in the United Kingdom by the FSA, is acting exclusively as financial adviser to and broker to IQE plc and for no one else in connection with the Placing and is not advising any other person or treating any other person as its customer in relation to or in connection with the Placing and is not advising any other person or treating any other person as its customer in relation to the matters referred to in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Canaccord or for providing advice in relation to the Placing or any matter referred to in this announcement.

 

The distribution of this announcement and/or issue of Placing Shares pursuant to the Placing or otherwise in certain jurisdictions outside the United Kingdom may be restricted by law. Persons who seek to participate in the Placing must inform themselves about and observe any such restrictions. In particular, this announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for Placing Shares in the United States, Canada, Australia, Japan, South Africa, New Zealand or the Republic of Ireland or any other jurisdiction in which such offer or solicitation, publication or distribution is or would be unlawful.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIUGURUPUPPGQR
Date   Source Headline
1st Jul 20269:15 amRNSIQE plc: Total Voting Rights and Block Admission
1st Jul 20267:00 amRNSIQE plc: Appointment of Non-executive Directors
30th Jun 20263:28 pmRNSResults of Annual General Meeting
30th Jun 20267:00 amRNSIQE plc: Notice of AGM
25th Jun 20263:34 pmRNSIQE plc: Holding(s) in Company
19th Jun 20267:00 amRNSExercise of Warrants, Issue of Equity and TVR
16th Jun 20268:21 amRNSExercise of Warrants, Issue of Equity and TVR
15th Jun 20267:00 amRNSIQE plc: Tower Semiconductor InP supply agreement
10th Jun 20262:57 pmRNSIQE plc: Director Notification and AGM Update
3rd Jun 20265:37 pmRNSIQE plc: Holding(s) in Company
3rd Jun 20267:00 amRNSIQE plc: Notice of AGM and Annual Report
2nd Jun 202612:09 pmRNSIQE plc: Total Voting Rights
1st Jun 20264:21 pmRNSHolding(s) in Company
29th May 20269:46 amRNSIQE plc: Director/PDMR Shareholding
28th May 20267:05 amRNSIQE plc: FY 2025 Financial Results
28th May 20267:00 amRNSIQE plc: Completion of Fundraising
20th May 20267:00 amRNSIQE plc: Notice of Results
18th May 20269:31 amRNSIQE plc: Holding(s) in Company
15th May 202612:14 pmRNSIQE plc: Results of General Meeting
14th May 202611:29 amRNSIQE plc: Holding(s) in Company
12th May 20262:14 pmRNSIQE plc: Holding(s) in Company
11th May 202612:38 pmRNSIQE plc: Holding(s) in Company
7th May 20264:59 pmRNSIQE plc: Holding(s) in Company
6th May 20262:16 pmRNSIQE plc: Holding(s) in Company
5th May 202612:00 pmRNSIQE plc: Holding(s) in Company
1st May 20267:00 amRNSIQE plc: Total Voting Rights
30th Apr 20268:33 amRNSForm 8.3 IQE PLC 20260429
29th Apr 20262:55 pmRNSForm 8.3 IQE PLC
29th Apr 20261:05 pmRNSIQE plc: Circular & Notice of General Meeting
29th Apr 20267:00 amRNSForm 8.3 IQE PLC 20260428
28th Apr 20263:00 pmRNSForm 8.3 IQE PLC
28th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) IQE PLC
28th Apr 20269:19 amRNSForm 8.3 IQE PLC 20260427
28th Apr 20267:45 amRNSDisclosure Table
28th Apr 20267:00 amRNSIQE plc: Results of Placing and Retail Offer
28th Apr 20267:00 amRNSForm 8.3 - IQE PLC - PengXi Capital Limited
27th Apr 20265:00 pmRNSIQE plc: RetailBook Offer
27th Apr 20264:55 pmRNSIQE plc: Conclusion of Strategic Review
27th Apr 202612:48 pmRNSForm 8.3 IQE PLC
27th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) IQE PLC
27th Apr 202611:40 amRNSForm 8.5 (EPT/RI) IQE PLC - Replacement
27th Apr 202610:25 amRNSForm 8.5 (EPT/RI) - IQE plc
27th Apr 20267:00 amRNSIQE plc: Rule 2.9 Announcement
24th Apr 20261:56 pmRNSForm 8.3 IQE PLC
24th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) IQE PLC
24th Apr 202611:40 amRNSForm 8.3 - IQE Plc
24th Apr 202611:12 amRNSForm 8.5 (EPT/RI) - IQE plc
24th Apr 202610:41 amRNSForm 8.3 IQE PLC 20260423
23rd Apr 20262:58 pmRNSForm 8.3 IQE PLC
23rd Apr 20262:22 pmRNSForm 8.3 - IQE PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.